AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 273: R287-R292, 1997;
0363-6119/97 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sejourne, F.
Right arrow Articles by Rubinstein, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sejourne, F.
Right arrow Articles by Rubinstein, I.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 273, Issue 1 287-R292, Copyright © 1997 by American Physiological Society


ARTICLES

Mechanisms of vasodilation elicited by VIP in sterically stabilized liposomes in vivo

F. Sejourne, H. Suzuki, H. Alkan-Onyuksel, X. P. Gao, H. Ikezaki and I. Rubinstein
Department of Pharmaceutics and Pharmacodynamics, University of Illinois at Chicago, USA.

The purpose of this study was to begin to determine the mechanisms underlying vasodilation elicited by vasoactive intestinal peptide (VIP) in sterically stabilized liposomes (SSL) in the in situ peripheral microcirculation. Using intravital microscopy, we found that suffusion of VIP in SSL (0.42 and 0.85 nmol) onto the hamster cheek pouch for 1 h elicited significant and prolonged concentration-dependent vasodilation (P < 0.05). Suffusion of VIP in SSL (0.1 nmol) for 7 min elicited a qualitatively similar response, although its magnitude was significantly smaller than that elicited by 1 h of suffusion of VIP in SSL (P < 0.05). The VIP-receptor antagonist VIP-(10-28), but not the amino-terminal fragment VIP-(1-12), significantly attenuated and delayed the onset of VIP in SSL-induced vasodilation (P < 0.05). The nitric oxide (NO) synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME), but not NG-nitro-D-arginine methyl ester (D-NAME), abrogated VIP in SSL-induced responses. We conclude that VIP in SSL elicits significant and prolonged vasodilation in the in situ peripheral microcirculation, which is specific, partly receptor dependent, and partly transduced by the L-arginine/NO biosynthetic pathway.


This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
B. W. Wilkins, B. J. Wong, N. J. Tublitz, G. R. McCord, and C. T. Minson
Vasoactive intestinal peptide fragment VIP10-28 and active vasodilation in human skin
J Appl Physiol, December 1, 2005; 99(6): 2294 - 2301.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
T. Tsueshita, S. Gandhi, H. Onyuksel, and I. Rubinstein
Phospholipids modulate the biophysical properties and vasoactivity of PACAP-(138)
J Appl Physiol, October 1, 2002; 93(4): 1377 - 1383.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
T. Tsueshita, S. Gandhi, and I. Rubinstein
Effects of quinupristin/dalfopristin on vasomotor tone in the intact peripheral microcirculation
J. Antimicrob. Chemother., June 1, 2002; 49(6): 1027 - 1030.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
I. Rubinstein, R. Chandilawa, S. Dagar, D. Hong, and X.-P. Gao
Adenosine A1 receptors mediate plasma exudation from the oral mucosa
J Appl Physiol, August 1, 2001; 91(2): 552 - 560.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
H. Suzuki, H. Ikezaki, R. Chandiwala, D. Hong, and I. Rubinstein
Effects of Pseudomonas aeruginosa endotoxin on vasodilation in the intact spinotrapezius muscle
J Appl Physiol, July 1, 2001; 91(1): 351 - 356.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
I. Rubinstein
Smokeless tobacco potentiates VIP-induced DNA synthesis and inactivates NEP 24.11 in oral keratinocytes
Am J Physiol Cell Physiol, February 1, 2000; 278(2): C391 - C396.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. Ikezaki, M. Patel, H. Onyuksel, S. R. Akhter, X.-P. Gao, and I. Rubinstein
Exogenous calmodulin potentiates vasodilation elicited by phospholipid-associated VIP in vivo
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1999; 276(5): R1359 - R1365.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. Ikezaki, H. Onyuksel, and I. Rubinstein
Liposomal VIP attenuates phenylephrine- and ANG II-induced vasoconstriction in vivo
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R588 - R595.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. Ikezaki, S. Paul, H. Alkan-Onyuksel, M. Patel, X.-P. Gao, and I. Rubinstein
Vasodilation elicited by liposomal VIP is unimpeded by anti-VIP antibody in hamster cheek pouch
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1998; 275(1): R56 - R62.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
X.-P. Gao, S. R. Akhter, and I. Rubinstein
Ovalbumin increases macromolecular efflux from the in situ nasal mucosa of allergic hamsters
J Appl Physiol, January 1, 1998; 84(1): 169 - 176.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online